Skip to content

Drug interactions

Rucaparib + Zafirlukast

Severity: Minor

Rucaparib and Zafirlukast: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rucaparib inhibits CYP2C9 and may increase zafirlukast concentrations. The clinical effect is likely small but could increase zafirlukast adverse effects.

What this interaction means in plain words

Rucaparib and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Rucaparib belongs to Oncology; Zafirlukast belongs to Respiratory.

Evidence level: Low

Why it happens

Rucaparib inhibits CYP2C9, reducing zafirlukast metabolism.

What to do

Monitor for zafirlukast adverse effects such as headache or gastrointestinal upset. Reduce the zafirlukast dose if clinically indicated.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rucaparib and Zafirlukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Rucaparib with Zafirlukast?

MediHelp rates the interaction as minor. Rucaparib and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Rucaparib inhibits CYP2C9 and may increase zafirlukast concentrations. The clinical effect is likely small but could increase zafirlukast adverse effects.

How serious is the interaction between Rucaparib and Zafirlukast?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for zafirlukast adverse effects such as headache or gastrointestinal upset. Reduce the zafirlukast dose if clinically indicated.

What other medicines interact with Zafirlukast?

MediHelp also lists interactions of Zafirlukast with, for example, Pimozide, Lomitapide, Nilotinib. The full list is on the Zafirlukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in